Health Costs

The MIDTERMS

KFF Health Tracking Poll: MAHA and the Midterms

Chemical food additive and pesticide concerns associated with the Make America Health Again (MAHA) movement are shared broadly across the public. But when it comes to voters, health care costs are a higher priority and bigger motivator, even among MAHA supporters, a new KFF Health Tracking Poll finds. When asked to identify their most important health priority for government to address, far more MAHA-supporting voters identify lowering the cost of health care (42%) than other issues more closely associated with the movement.

Affordable care act

ACA Marketplace Survey Feature Image - Website

Cost Concerns and Coverage Changes: A Follow-Up Survey of ACA Marketplace Enrollees

This KFF survey is a follow-up survey of adults who had ACA Marketplace insurance in 2025. The survey examines the cost concerns and coverage changes of Marketplace enrollees following the end of the enhanced premium tax credits and finds that half of returning enrollees say their health care costs are “a lot higher” and most expect to cut back on basic household expenses to afford coverage.

Health System Tracker

What Are the Recent Trends in Employer-Based Health Coverage? Employer-sponsored health insurance is the largest source of health coverage for people under 65, but its reach is uneven.

How Does U.S. Life Expectancy Compare to Other Countries? The life expectancy gap between the U.S. and peer countries decreased from 4.1 years in 2023 to 3.7 years in 2024 as U.S. mortality dropped.

How Does Cost Affect Access to Health Care? In 2024, about 1 in 6 adults reported delaying or not getting healthcare due to cost, including medical or mental health care.

How Does Health Spending in the U.S. Compare to Other Countries? While the U.S. still spends the most in total dollars, eight OECD nations had a higher percentage increase in per-person health spending in 2024.

Stay informed.

Stay informed.

Filter

741 - 750 of 1,582 Results

  • The Role of National Firms in Medicare+Choice

    Report

    This report addresses national managed care firms participation in M+C and the factors influencing their decision processes about M+C products. Based on interviews with executives and senior staff of national managed care firms, this report examines how eight national firms strategically position their M+C product, including the process that firms use when making decisions and the key factors they say most influence their decisions related to participation. Report

  • Medicare Cost-Sharing: Implications for Beneficiaries

    Event Date:
    Event

    Tricia Neuman, Vice President and Director of the Medicare Policy Project, testified on behalf of herself and Thomas Rice, Ph.D., of UCLA's School of Public Health, before the House Ways and Means Subcommittee on Health on cost-sharing requirements under Medicare and supplemental Medigap policies. The statement reviews Medicare beneficiaries' current cost-sharing responsibilities, the evidence on the impact of out-of-pocket costs on health-care utilization, and the implications for proposals that would modify Medicare's cost-sharing structure.

  • Section 5: Structure of the Health Care Marketplace

    Other Post

    Pages: 1 2 3 4 5 6 7 8 9 10 11 12 next > Exhibit 5.1: Health Care Employment and Share of Total Non-Farm Employment, 1990-2005p Health care employment as a proportion of all non-farm employment has increased fairly steadily since the early 1990s. In 2005p, 9.2% of all workers, or 12.3 million people, held health care jobs, up from 7.5% (8.2 million) in 1990. Health Care Employment (object placeholder) Notes: Not seasonally adjusted.…

  • Trends in Medicare Supplemental Insurance and Prescription Drug Benefits, 1996-2001Data Update

    Report

    Trends in Medicare Supplemental Insurance and Prescription Drug Benefits, 1996-2001 Data Update This data update provides estimates of supplemental insurance and prescription drug coverage rates and trends between 1996 and 2001, which will help to provide important context for assessing future changes in supplemental insurance and drug coverage rates after provisions of the Medicare drug benefit take effect. Report (.pdf)

  • Kaiser Family Foundation/Harvard University National Survey of Americans’ Views on Consumer Protection in Managed Care

    Report

    A survey of 1,204 adults on Americans' views on consumer protections and government regulation of managed care and the President's "Consumer Bill of Rights." The survey was conducted for the Foundation and Harvard University by Princeton Survey Research Associates. Additional questions were asked as part of a national omnibus telephone survey of 1,012 adults between January 8-12, 1998. TOPLINE Download CHARTPACK Download NEWS RELEASE Download

  • The Changing Medicaid Managed Care Market

    Report

    Trends in Commercial Plans' Participation This background paper analyzes the trends in commercial plan participation in the Medicaid market by using a database specifically designed for this purpose. It examines changes from mid-1996 to mid-1997 in the types of full-risk plans serving Medicaid Beneficiaries. It also looks at trends through mid-1998 for the 15 states with the largest number of Medicaid enrollees. Background Paper: : Trends in Commercial Plans' Particpation

  • Key Findings: Kaiser Health Tracking Poll: Election 2008 — June 2007

    Poll Finding

    This document presents key findings from the June 2007 Kaiser Health Tracking Poll: Election 2008, which tracks changes in the saliency of health as a political and policy priority, what the public’s priorities are for a health reform plan and whether any candidates are breaking through with the public with their health reform plans   Key Findings (.pdf)

  • Pharmaceutical Policy and Pricing: Are Other Countries Getting Greater Value?

    Event Date:
    Event

    Spending on prescription drugs in the U.S. rose at a faster clip in 2009 than spending for hospital and physician care, a trend that is expected to continue through 2020. The desire to get a handle on drug spending is a focus not only in the U.S. but in other countries as well. What are some strategies used in our country and in the UK, Germany and France to control pharmaceutical spending? How well are…